U.S. Acne Treatment Market 2022 Trend By Products And End Users, Forecast Till 2027
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/u-s-acne-treatment-market-106565
Top Players Covered in the U.S. Acne Treatment Market Research Report Are Bausch Health Companies Inc. (Canada), GALDERMA (Switzerland), Pfizer Inc. (U.S.), Johnson Johnson Services, Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Allergan (Ireland), Mayne Pharma Group Limited (Australia), Sun Pharmaceutical Industries Ltd. (India), Reckitt Benckiser Group PLC. (U.K.), Padagis (U.S.), Almirall, S.A (Spain) and other key market players.
Industry Development
- September 2021- Zelira Therapeutics Ltd. announced its initial line of products, RAF FIVE, through the subsidiary brand Ilera Derm LLC.
List of Key Players Profiled in the Report
- Bausch Health Companies Inc. (Canada)
- GALDERMA (Switzerland)
- Pfizer Inc. (U.S.)
- Johnson Johnson Services, Inc. (U.S.)
- GlaxoSmithKline Plc. (U.K.)
- Allergan (Ireland)
- Mayne Pharma Group Limited (Australia)
- Sun Pharmaceutical Industries Ltd. (India)
- Reckitt Benckiser Group PLC. (U.K.)
- Padagis (U.S.)
- Almirall, S.A (Spain)
Table of Contents
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Incidence Prevalence of Acne, U.S. (2021)
- New Product Launches
- Pipeline Analysis
- Key Industry Developments
- Current Unmet Medical Needs
- Treatment Algorithm for the Management of Acne Vulgaris in Adolescents Young Adults
- Impact of COVID-19 on U.S. Acne Treatment Market
- Regulatory Reimbursement Scenario, U.S.
- S. Acne Treatment Market Analysis, Insights and Forecast, 2018-2029
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Retinoids
- Antibiotics
- Isotretinoin
- Others
- Market Analysis, Insights and Forecast – Treatment Modality
- Oral
- Topical
- Market Analysis, Insights and Forecast – Age Group
- 10 to 17
- 18 to 44
- 45 to 64
- 65 and above
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
